Bogart Wealth LLC Boosts Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Bogart Wealth LLC increased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 66.3% in the 4th quarter, Holdings Channel.com reports. The fund owned 434 shares of the financial services provider’s stock after acquiring an additional 173 shares during the quarter. Bogart Wealth LLC’s holdings in iShares Biotechnology ETF were worth $57,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. SPC Financial Inc. lifted its position in iShares Biotechnology ETF by 2.4% in the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after buying an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management lifted its position in iShares Biotechnology ETF by 2.7% in the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after buying an additional 76 shares during the last quarter. Chicago Partners Investment Group LLC lifted its position in iShares Biotechnology ETF by 2.5% in the fourth quarter. Chicago Partners Investment Group LLC now owns 3,783 shares of the financial services provider’s stock valued at $510,000 after buying an additional 94 shares during the last quarter. Capital Investment Advisors LLC lifted its position in iShares Biotechnology ETF by 1.0% in the fourth quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock valued at $1,381,000 after buying an additional 99 shares during the last quarter. Finally, Magnus Financial Group LLC lifted its position in iShares Biotechnology ETF by 0.8% in the fourth quarter. Magnus Financial Group LLC now owns 12,967 shares of the financial services provider’s stock valued at $1,714,000 after buying an additional 104 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.4 %

NASDAQ IBB opened at $136.55 on Friday. The firm’s 50-day moving average is $135.73 and its two-hundred day moving average is $141.03. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.